Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis-Reference-Cited by-同舟云学术

Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis

Published:2023-04 Issue:4 Volume:61 Page:106754
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Cao Yuran,Li Yi,Guo Beining,Zhang Jing,Wu Xiaojie,Yu Jicheng,Cao Guoying,Fan Yaxin,Wu Hailan

Funder

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference24 articles.

1. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria;Hu;Int J Antimicrob Agents,2014

2. Effects of the ornidazole enantiomers on the central nervous system: involvement of the GABAA receptor;Wei;Chem-Biol Interact,2015

3. Comparative study of ornidazole enantiomers on the toxic and side effects to central nervous system in mice;Sun;J China Pharm Univ,2008

4. In vitro bactericidal property of levornidazole against Bacteroides fragilis studied by time-kill assay and sigmoid Emax model analysis;Hu;Int J Antimicrob Agents,2015

5. Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole;Sprandel;Diagn Microbiol Infect Dis,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing;Journal of Antimicrobial Chemotherapy;2024-08-01

2. Titration and dose calculation of vaccine stock;Bioreactor Design Concepts for Viral Vaccine Production;2024